The Hematologic Oncology Department at Cancer Treatment Centers of America® (CTCA) provides advanced medical therapies for patients with blood-related diseases, including leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma.
Our hematologic oncology team has expertise in treating hematologic diseases using advanced technology and a personalized approach. We use state-of-the-art diagnostic tests to develop an individualized treatment plan that's tailored to your needs.
Helping you maintain your quality of life
Our hematology oncology team will work with the rest of your care team to support you throughout your treatment.
For example, your dietitian may recommend a healthy diet to nutritionally fortify your body, and your naturopathic clincian may recommend natural therapies to help reduce side effects, such as neuropathy. Your rehabilitation therapist may recommend safe levels of physical activity to help you stay active and independent.
Additionally, your pain management practitioner may use various techniques to help alleviate discomfort and control bone and neuropathic pain, while your mind-body therapist may provide counseling and relaxation techniques.
The hematologic oncology team at CTCA in Metro Atlanta
The doctors in the hematologic oncology program at Cancer Treatment Centers of America® (CTCA) in Metro Atlanta are dedicated to fighting the wide variety of blood cancers using advanced and innovative medical techniques. We offer an array of treatments, including autologous transplant services, for patients with newly diagnosed blood cancer and relapsed/refractory blood cancer.
At the same time, by addressing the side effects of cancer and its treatment with supportive care therapies, our care team strives to help patients reduce treatment interruptions and improve their quality of life. In addition to conventional treatment approaches, your care team may help you determine whether you qualify for one of our ongoing clinical trials, which may offer access to new, innovative treatments for your type of cancer.
From diagnostic testing to transplants and other treatments, all aspects of our comprehensive hematologic oncology program are delivered under one roof, so you don’t have to travel from location to location.
Our program is led by Drs. Brion Randolph, Damien Hansra and Mary Ninan. A Medical Oncologist and Hematologist, Dr. Randolph is the Medical Director of Hematologic Oncology at CTCA® in Metro Atlanta. His areas of expertise include multiple myeloma, stem cell transplants and clinical research. Prior to joining CTCA, Dr. Randolph conducted research at the University of South Carolina Medical School, Baylor College of Medicine and Johns Hopkins Medical Institute in Baltimore, Maryland. He is currently the principal investigator for hematology clinical trials at our Atlanta-area hospital.
Dr. Hansra is a Medical Oncologist who is board certified in internal medicine, medical oncology and hematologic oncology, and specializes in treating patients with hematologic malignancies. He served as an oncologist and hematologist in Miami, Florida, and is a member of organizations including the American Society of Clinical Oncology and the American Society of Hematology. Dr. Ninan is a Hematologic Oncologist who is board certified in internal medicine, hematology and medical oncology. Prior to joining CTCA, Dr. Ninan was a professor of hematology and oncology at the University of Texas Medical Branch in Galveston. Her areas of expertise include lymphoma and clinical research.